OMERACT 6 brings new perspectives to rheumatology measurement research

Journal of Rheumatology

Volumn 30, Issue 4, 2003, Pages 639-641

  Saag, Kenneth G ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BONE INJURY; BONE REMODELING; CLINICAL RESEARCH; DISEASE ACTIVITY; ECONOMICS; EDITORIAL; JOINT EXAMINATION; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SCLERODERMA; SYSTEMIC SCLEROSIS; UNITED STATES; WORKSHOP;

HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 0037383419     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (21)

1. Brooks P, Tugwell P, Strand CV, Simon L, Boers M. OMERACT 6: International Consensus Conference on Outcome Measures in Rheumatology. J Rheumatol 2003;30:866-7.
2. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Health and Medicine. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1253-8.
3. Gabriel SE, Tugwell P, O'Brien B, et al. Report of the OMERACT Task Force on Economic Evaluation. J Rheumatol 1999;26:203-6.
4. Gabriel SE, Tugwell P, Drummond M. Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology. Ann Rheum Dis 2002;61:370-3.
5. Coyle D, Welch V, Shea B, Gabriel SE, Drummond M, Tugwell P. Issues of consensus and debate for economic evaluation in rheumatology. J Rheumatol 2001;28:642-7.
6. Gabriel S, Drummond M, Maetzel A, et al. OMERACT 6 Economics Working Group Report: A proposal for a reference case for economic evaluation in rheumatoid arthritis. J Rheumatol 2003;30:886-90.
7. Maetzel A, Tugwell P, Boers M, et al. Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case. J Rheumatol 2003;30:891-6.
8. Reece R, Kraan M, Radjenovic A, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002;46:366-72.
9. McQueen FM, Benton N, Crabbe J, et al. Tracking individual lesions using MR and XR over the first 2 years of disease. Ann Rheum Dis 2001;60(859-68).
10. Conaghan P, Edmonds J, Emery P, et al. Magnetic resonance imaging in rheumatoid arthritis: summary of OMERACT activities, current status and plans. J Rheumatol 2001;28:1158-61.
11. Boers M, Brooks P, Strand V, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
12. Bathon JM, Martin RW, Fleischman RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
13. Lipsky PE, van der Heijde DMFM, St. Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
14. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis. Arthritis Rheum 2000;43:495-505.
15. Berkanovic E, Hurwicz ML, Lachenbruch PA. Concord and discrepant views of patients' physical functioning. Arthritis Care Res 1995;8:94-101.
16. Criswell LA, Henke CJ. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis? J Rheumatol 1995;22:829-35.
17. Carr A, Hewlett S, Hughes R, et al. Rheumatology outcomes: the patient's perspective. J Rheumatol 2003;30:880-3.
18. Kirwan J, Heiberg T, Hewlett S, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol 2003;30:868-72.
19. Kvien TK, Heiberg T. Patient perspective in outcome assessments - perceptions or something more? J Rheumatol 2003;30:873-6.
20. Hewlett S. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 2003;30:877-9.
21. Quest E, Aanerud GJ, Kaarud S, et al. Patients' perspective. J Rheumatol 2003;30:884-5.